Literature DB >> 25600951

Segmental cholangiectasia clinically worrisome for cholangiocarcinoma: comparison with recurrent pyogenic cholangitis.

Lei Zhao1, Mojgan Hosseini2, Rebecca Wilcox3, Qiang Liu4, Terri Crook5, Jerome B Taxy6, Linda Ferrell2, John Hart7.   

Abstract

The aim of this study was to review the clinical, radiographic, and pathologic features of cases of benign segmental cholangiectasia in non-Asian US patients with clinical concern for cholangiocarcinoma and compare these features with cases of recurrent pyogenic cholangitis (RPC) in Asian patients. A total of 10 non-Asian US patients with benign segmental cholangiectasia were included in this study. Nine of them underwent partial hepatic resection due to cholangiographic findings of segmental cholangiectasia with mural thickening and/or proximal biliary stricture. One was found to have markedly dilated and thickened intrahepatic bile ducts at the time of autopsy. Clinical and radiographic findings were reviewed. Elastin stains and immunostains for immunoglobulin G4, cluster of differentiation (CD1a), and Langerin were performed. Six comparison cases of RPC in Asian US patients were also examined. Histologic examination of resection specimens revealed markedly dilated large intrahepatic bile ducts with variable degrees of mural fibrosis, periductal gland hyperplasia, inflammation, and liver parenchymal atrophy. These changes were not associated with a ductular reaction. There was no evidence of biliary dysplasia or biliary cirrhosis in any cases. No gross or microscopic feature definitively separated the Asian from non-Asian patients. The etiology of this disorder in non-Asian US patients is unclear. It does not appear to represent a localized variant of Caroli disease or primary sclerosing cholangitis. The high degree of similarity shared by these cases and classic RPC suggests a common pathogenic mechanism, although the pathologic features tend to be less well developed in the cases from the non-Asian US patients.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholangiectasia; Hepatolithiasis; Recurrent pyogenic cholangitis; Sclerosing cholangitis

Mesh:

Year:  2014        PMID: 25600951     DOI: 10.1016/j.humpath.2014.11.019

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  1 in total

1.  Natural Course and Risk of Cholangiocarcinoma in Patients with Recurrent Pyogenic Cholangitis: A Retrospective Cohort Study.

Authors:  Min Su You; Sang Hyub Lee; Jinwoo Kang; Young Hoon Choi; Jin Ho Choi; Bang-Sup Shin; Gunn Huh; Woo Hyun Paik; Ji Kon Ryu; Yong-Tae Kim; Dong Kee Jang; Jun Kyu Lee
Journal:  Gut Liver       Date:  2019-05-15       Impact factor: 4.519

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.